BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

48 related articles for article (PubMed ID: 8236177)

  • 1. Villoglandular Adenocarcinoma of the Uterine Cervix: A Case Report.
    Park S; Pak MG; Park JW
    J Menopausal Med; 2023 Dec; 29(3):150-153. PubMed ID: 38230601
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An Unusual Presentation of Villoglandular Papillary Adenocarcinoma in a Perimenopausal Woman.
    Nair PR; Inamdar SA; Kalambe MA; Dewangan A
    Cureus; 2024 Feb; 16(2):e54374. PubMed ID: 38505429
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Villoglandular adenocarcinoma of cervix: pathologic features, clinical management, and outcome.
    Guo P; Liu P; Yang J; Ren T; Xiang Y
    Cancer Manag Res; 2018; 10():3955-3961. PubMed ID: 30310316
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Villoglandular papillary adenocarcinoma: case report.
    Salek G; Lalya I; Rahali DM; Dehayni M
    Pan Afr Med J; 2016; 25():232. PubMed ID: 28293348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Villograndular adenocarcinoma of uterine cervix: a case report].
    Reale D; Vitullo G; Di Virgilio M; Trubiani O; Pizzicannella G
    Pathologica; 2001 Apr; 93(2):128-31. PubMed ID: 11428290
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Well-Differentiated villoglandular adenocarcinoma of the uterine cervix: a report of 15 cases including two with lymph node metastasis.
    Khunamornpong S; Maleemonkol S; Siriaunkgul S; Pantusart A
    J Med Assoc Thai; 2001 Jun; 84(6):882-8. PubMed ID: 11556470
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Villoglandular papillary adenocarcinoma of the uterine cervix with immunohistochemical characteristics.
    Polat A; Düsmez D; Pata O; Aydin O; Egilmez R
    J Exp Clin Cancer Res; 2002 Sep; 21(3):425-7. PubMed ID: 12385589
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic factors affecting the outcome of early cervical cancer treated with radical hysterectomy and post-operative adjuvant therapy.
    Liu MT; Hsu JC; Liu WS; Wang AY; Huang WT; Chang TH; Pi CP; Huang CY; Huang CC; Chou PH; Chen TH
    Eur J Cancer Care (Engl); 2008 Mar; 17(2):174-81. PubMed ID: 18302655
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Stage II endometrioid adenocarcinoma of the endometrium: clinical implications of cervical stromal invasion.
    Orezzoli JP; Sioletic S; Olawaiye A; Oliva E; del Carmen MG
    Gynecol Oncol; 2009 Jun; 113(3):316-23. PubMed ID: 19345400
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Villous glandular adenocarcinoma of the uterine cervix. A subtype with favourable prognosis?].
    Reed W; Abeler VM; Tropé CG
    Tidsskr Nor Laegeforen; 1993 Aug; 113(20):2569-71. PubMed ID: 8236177
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Well-differentiated papillary villoglandular adenocarcinoma of the uterine cervix.
    Datta CK
    W V Med J; 1997; 93(4):186-8. PubMed ID: 9274143
    [TBL] [Abstract][Full Text] [Related]  

  • 12.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 13.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 14.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 15.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 16.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 17.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 18.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 3.